| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0095 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |